What is the IEEPA tariff refund program and who qualifies?

The IEEPA (International Emergency Economic Powers Act) tariff refund program allows U.S. importers of medical technology and related products to claim recovery of tariffs paid under specific trade authorities. Medtech manufacturers and distributors who imported eligible goods are generally qualifying parties. The specific product categories and eligibility criteria are outlined in official guidance from U.S. Customs and Border Protection (CBP). Companies should consult AdvaMed resources or customs brokers to determine eligibility for their particular product portfolio.

How much time do companies have to file for IEEPA tariff refunds?

While the article does not specify exact claim window details, tariff refund opportunities typically operate under statute-of-limitations rules. Historically, U.S. customs refunds must be claimed within one year of payment or within timeframes specified in CBP guidance. Supply chain teams should act immediately to audit import records and gather documentation, as delays risk missing the filing deadline. Contact your customs broker or trade counsel for precise deadlines applicable to your company.

What documentation will medtech companies need to support refund claims?

Successful refund claims generally require: commercial invoices, bills of lading, entry/import documentation, proof of tariff payment, and product classification records demonstrating tariff code assignment. Medtech companies should coordinate with procurement and logistics teams to compile a comprehensive audit trail showing goods crossed U.S. borders under qualifying tariff authorities. Organized digital records will accelerate the claim submission process and reduce rejection risk.

How does this tariff refund affect medtech supply chain strategy going forward?

This refund program creates a near-term working capital benefit, but supply chain leaders should also use it as a catalyst for broader tariff exposure assessment. Companies should map current and historical tariff payments across sourcing regions, evaluate sourcing diversification to reduce tariff concentration, and establish systematic tracking of trade policy changes. The medtech sector remains subject to evolving tariff frameworks; proactive management now strengthens resilience against future policy shifts.

Should medtech companies engage external trade consultants for IEEPA refund claims?

Engaging customs brokers or trade counsel is highly advisable, particularly for companies with complex import portfolios or large tariff payment volumes. These specialists understand CBP procedures, documentation requirements, and common claim rejection triggers. While there are costs associated with external support, the expertise typically results in faster processing, higher claim approval rates, and reduced compliance risk—often justifying the investment given the scale of potential refunds.

Trade Policy & Tariffs

High Impact

IEEPA Tariff Refunds for Medtech: What Companies Need Know

Sep 2, 2026

Get tomorrow's supply chain signal

Daily supply-chain brief. Free, unsubscribe anytime.

The signal

S. International Emergency Economic Powers Act (IEEPA) tariff refund program is opening opportunities for the medical technology sector to recover duties paid on affected imports. This announcement from the Advanced Medical Technology Association (AdvaMed) signals a significant shift in trade policy administration for the healthcare industry, potentially restoring millions in working capital across medtech supply chains. S.

government procurement and international trade frameworks. For supply chain professionals managing medtech operations, this development carries dual implications: immediate financial recovery through refund claims, and longer-term strategic reassessment of tariff exposure and duty allocation across sourcing networks. Companies must quickly audit their import records, categorize shipments eligible for recovery, and prepare supporting documentation for regulatory submission. The window for claiming refunds is typically time-sensitive, making rapid internal coordination between procurement, customs, and finance teams essential.

S. trade environment for regulated industries. Medtech supply chains, already subject to stringent compliance requirements around Cold Chain integrity, product traceability, and FDA validation, must now integrate tariff claim management into their operational workflows. Organizations that proactively map their tariff exposure and establish systematic claim processes will capture the most value from this refund opportunity while building resilience against future trade policy shifts.

#healthcare-compliance

Frequently Asked Questions

What This Means for Your Supply Chain

Simulation Suggestion

this month

What if medtech companies can claim 50% of tariffs paid over the past 3 years?

Simulate the impact of reclaiming tariff duties on working capital position, inventory carrying costs, and cash flow scenarios. Model the effect of recovered capital on ability to fund capacity expansion, R&D initiatives, or supply chain resilience investments. Consider timing of claim approvals and cash inflows.

Run this scenario

Simulation Suggestion

this month

What if only 60% of tariff claims are approved due to documentation gaps?

Model claim approval rate variance based on documentation completeness and CBP processing timelines. Simulate scenario where incomplete claims face rejection, requiring rework and resubmission with 3-6 month delays. Assess impact on cash flow forecasting and working capital planning.

Run this scenario

Simulation Suggestion

strategic

What if tariff refunds enable accelerated inventory buildup for supply chain resilience?

Simulate redeployment of recovered tariff capital toward strategic inventory reserves, nearshoring buffers, or dual-sourcing initiatives. Model impact on lead times, service level targets, and vulnerability to future supply disruptions. Compare working capital efficiency with and without buffer stock.

Run this scenario

Go deeper:

Supply Chain Digital Twin: The 2026 Guide

How operators model end-to-end supply chains to see how tariffs, supplier shocks, and regulatory changes ripple across cost, service, risk, and time.

Get the daily supply chain briefing

Top stories, Pulse score, and disruption alerts. No spam. Unsubscribe anytime.

The signal

Frequently Asked Questions

What This Means for Your Supply Chain

Related Articles